Bernard Khor

Oregon Health & Science University — United States

Immunology and Microbiology · Life Sciences

27h-index4.6kcitations51works19.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(23), T-cell and B-cell Immunology(16), Blood Coagulation and Thrombosis Mechanisms(7), CAR-T cell therapy research(7), Venous Thromboembolism Diagnosis and Management(6)

Publications47 total

Defining a novel DYRK1A-gp130/IL-6R-pSTAT axis that regulates Th17 differentiation
ImmunoHorizons·2025· 2 citedOpen Access
Down syndrome: insights into autoimmune mechanisms
Nature Reviews Rheumatology·2023· 17 citedOpen Access
FRTX-02, a selective and potent inhibitor of DYRK1A, modulates inflammatory pathways in mouse models of psoriasis and atopic dermatitis
Journal of Translational Autoimmunity·2022· 9 citedOpen Access
Permutational immune analysis reveals architectural similarities between inflammaging, Down syndrome and autoimmunity
2021Open Access
Tonic interferon restricts pathogenic IL-17-driven inflammatory disease via balancing the microbiome
eLife·2021· 36 citedOpen Access
Author response: Tonic interferon restricts pathogenic IL-17-driven inflammatory disease via balancing the microbiome
2021Open Access
The Cyclin-Dependent Kinase 8 (CDK8) Inhibitor DCA Promotes a Tolerogenic Chemical Immunophenotype in CD4<sup>+</sup> T Cells via a Novel CDK8-GATA3-FOXP3 Pathway
Molecular and Cellular Biology·2021· 9 citedOpen Access
Tonic interferon restricts pathogenic IL-17-driven inflammatory disease via balancing the microbiome
2021· 1 citedOpen Access
Two roads diverged: Emerging lessons from <scp>IVIG</scp> about hemolysis
Transfusion·2021· 1 citedOpen Access
Opportunities, barriers, and recommendations in Down syndrome research
Translational Science of Rare Diseases·2021· 96 citedOpen Access
Decision letter: Seroconversion stages COVID19 into distinct pathophysiological states
2021Open Access
Cell Type– and Stimulation-Dependent Transcriptional Programs Regulated by Atg16L1 and Its Crohn's Disease Risk Variant T300A
The Journal of Immunology·2020· 7 citedOpen Access
The CDK8 inhibitor DCA promotes a tolerogenic chemical immunophenotype in CD4 <sup>+</sup> T cells via a novel CDK8-GATA3-FOXP3 pathway
2019Open Access
Distinct Tissue-Specific Roles for the Disease-Associated Autophagy Genes ATG16L2 and ATG16L1
The Journal of Immunology·2019· 31 citedOpen Access
Small-molecule studies identify CDK8 as a regulator of IL-10 in myeloid cells
Nature Chemical Biology·2017· 67 citedOpen Access
Regulatory T Cells: Central Concepts from Ontogeny to Therapy
Transfusion Medicine Reviews·2016· 15 citedOpen Access
Development of Chemical Probes for Investigation of Salt-Inducible Kinase Function <i>in Vivo</i>
ACS Chemical Biology·2016· 80 citedOpen Access
Factor <scp>V</scp><scp>L</scp>eiden
American Journal of Hematology·2015· 94 citedOpen Access
The kinase DYRK1A reciprocally regulates the differentiation of Th17 and regulatory T cells
eLife·2015· 102 citedOpen Access
Rac GTPases have opposite roles in T cells and dendritic cells in mucosal immune function (MUC8P.730)
The Journal of Immunology·2015
page 1 of 3Next →

Frequent Co-authors

Barry P. Sleckman(14), Ramnik J. Xavier(12), Alykhan F. Shamji(8), Thomas B. Sundberg(7), Azlann Arnett(7), Elizabeth M. Van Cott(6), Stuart L. Schreiber(6), Kara L. Conway(5), Daniel B. Graham(5), Nathanael S. Gray(5), Isabelle Marié(5), David T. Levy(5), John D Gagnon(4), Gautam Goel(4), Liv Johannessen(4), Keagan G. Moo(4), Petric Kuballa(3), Khoa Tran(3), Leslie N. Aldrich(3), Pauline H. Tan(3)